The nature of progression on long term active surveillance for confirmed Gleason grade group 1 prostate cancer in the modern era. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results